KRISTY SCHWEIGHARDT: Open Payments
NPI 1497230585 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,316 in 170 payments from 23 companies in 2025. Trend: 2023 $2,482 · 2024 $3,834 · 2025 $4,316
Food & beverage: $3,216Consulting: $1,000Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 12 | $1,358 |
| ABBVIE INC. | 27 | $513 |
| GENZYME CORPORATION | 13 | $399 |
| Novartis Pharmaceuticals Corporation | 20 | $248 |
| Janssen Biotech, Inc. | 13 | $218 |
| Regeneron Healthcare Solutions, Inc. | 10 | $213 |
| LEO Pharma Inc. | 10 | $186 |
| Galderma Laboratories, L.P. | 9 | $140 |
| Organon LLC | 17 | $133 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $120 |
Products named: Zoryve, DUPIXENT, RINVOQ, TREMFYA, ADBRY, SKYRIZI, OTEZLA, CIBINQO.
Industry payments across FL — which companies pay providers there.
